Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation

Purpose: This study evaluated the clinical efficacy and safety of bromfenac 0.09%, sodium hyaluronate 0.4% (SH) combination therapy, versus placebo and SH in a clinical model of pterygium I–III. Methods: A total of 166 eyes (99 patients) with pterygium grade I–III were randomized to bromfenac 0.09%...

Descripción completa

Detalles Bibliográficos
Autores principales: Chávez-Mondragón, Eduardo, Palacio, Claudia, Soto-Gómez, Abraham, Villanueva-Nájera, Miguel, De Wit-Carter, Guillermo, Suárez-Velasco, Ruben, Baiza-Duran, Leopoldo, Olvera-Montaño, Oscar, Muñoz-Villegas, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507105/
https://www.ncbi.nlm.nih.gov/pubmed/31118556
http://dx.doi.org/10.2147/OPTH.S203648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507105/
https://www.ncbi.nlm.nih.gov/pubmed/31118556
http://dx.doi.org/10.2147/OPTH.S203648

Ejemplares similares